Biogen Pharmachem P/E Ratio
Current P/E Ratio
27.0
High Valuation
High - Growth expectations or overvalued
Biogen Pharmachem (BIOGEN) P/E ratio is 27.0 (High), EPS (TTM) ₹0.01, current price ₹0.27 on BSE — High - Growth expectations or overvalued.
Current Valuation Metrics
P/E Ratio
27.0
Current Price
₹0.27
EPS (TTM)
₹0.01
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
59.4
Sector Median
20.61
Sector Rank
#11 of 394
Sector Percentile
2.8%
BIOGEN P/E Ratio — Valuation Signal & Historical Context
Biogen Pharmachem P/E 27.0 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Biogen Pharmachem screener.
- Stock appears overvalued with PE of 27.0, suggesting caution for new investments
- Trading at discount to sector average PE of 59.4
BIOGEN vs Financial Services Peers — P/E Ratio Comparison
Biogen Pharmachem P/E 27.0 vs Financial Services average 59.4, median 20.61 — range 0.02–1572.0.
Sector Average
59.4
Sector Median
20.61
Lowest P/E
0.02
Highest P/E
1572.0
Companies
394
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| SPV Global Trading | SPVGLOBAL | 0.02 | ₹3 | Low |
| Hindustan Housing | ZHINDHSG | 0.04 | ₹0 | Low |
| Winro Commercial | WINROC | 0.06 | ₹31 | Low |
| Speedage Commercials | ZSPEEDCO | 0.08 | ₹1 | Low |
| Sheraton Properties & Fi… | ZSHERAPR | 0.09 | ₹1 | Low |
| Sunrise Industrial Trader | SUNRINV | 0.14 | ₹0 | Low |
| Shikhar Leasing & Trading | SHIKHARLETR | 0.15 | ₹0 | Low |
| Ridhi Synthetics | RIDHISYN | 0.32 | ₹1 | Low |
| Available Finance | AVAILFC | 0.99 | ₹146 | Low |
| Jindal Poly Inv. & Fin. | JPOLYINVST | 1.3 | ₹1,040 | Low |